To better understand the function of these kidney-based glucagon receptors, Dr. Scherer and his colleagues used genetic techniques to eliminate the receptors in mice and compared them to mice ...

The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, according to a ...